I.D.33 RESSONANCIA MAGNETICA IMAGIOL (PRR)
TED · 373389-2026Award noticeawardedNo deadline given
Buyer
NameInstituto Português de Oncologia de Coimbra Francisco Gentil, EPE
CountryPT
Published2026-06-01
Deadline—
Value
Estimated€2,000,000 · 2,000,000 EUR
Awarded€1,999,999 · 1,999,999.3 EUR
WinnerConsorcio Philips- M. Nunes
Who already wins at this buyer
Firms with recorded awards from Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Excelência Robótica Unipessoal | LUSOPALEX - PRODUTOS DE SAÚDE, UNIPESSOAL, LDA | 1 | €1,901,500 | 2026-06-10 |
| General Electric Healthcare Portugal, Sociedade Unipessoal, Lda | 1 | €1,305,000 | 2026-05-08 |
| Excelência Robótica Unipessoal | SIEMENS HEALTHCARE,UNIPESSOAL,LDA | 1 | €1,065,000 | 2026-06-10 |
| LUSOPALEX – SOCIEDADE DISTRIBUIDORA DE PRODUTOS HOSPITALARES, UNIPESSOAL, LDA | GENERAL ELECTRIC HEALTHCARE PORTUGAL, SOCIEDADE UNIPESSOAL, LDA | 1 | €834,830 | 2026-07-22 |
| BACELAR & IRMAO, SA | 1 | €684,040 | 2026-06-02 |
CPV codes
33110000 Medical equipment & pharmaceuticalsDescription
I.D.33 RESSONANCIA MAGNETICA IMAGIOL (PRR)
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-27 | I.D.37 - INFR INFORMAT VNA IMAG (PRR) | Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE PT | 95% |
| 2026-05-26 | I.D.37 - DATACENTER (PRR) | Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE PT | 94% |
| 2026-05-26 | I.D.37 - SWITCHING (PRR) | Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE PT | 93% |
| 2026-06-02 | I.D.10 - MOBILIARIO ENFERMARIAS (PRR) | Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE PT | 93% |
| 2026-07-10 | I.D.41 - MAMOGRAFO 3 ECOGRAFOS (PRR) | Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE PT | 93% |
| 2026-06-10 | I.D. 10 SISTEMA CIRURGICO ROBOTICO (PRR) | Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE PT | 93% |